Application
Fig1: Western blot analysis of DDX1 on human DDX1 recombinant protein using anti-DDX1 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of DDX1 on HEK293 (1) and DDX1-hIgGFc transfected HEK293 (2) cell lysate using anti-DDX1 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of DDX1 on different cell lysate using anti-DDX1 antibody at 1/1,000 dilution. Positive control: Lane1: Hela Lane2: MCF-7 Lane3: A431 Lane4: PC-3 Lane5: Jurkat
Application
Fig4:ICC staining DDX1 (green) and Actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-DDX1 antibody. Counter stained with hematoxylin.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissue using anti-DDX1 antibody. Counter stained with hematoxylin.
Application
Fig7:Flow cytometric analysis of Hela cells with DDX1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).